VIMPAT DIN 02357615
Health Canada record
| Active ingredient(s) | LACOSAMIDE 50 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N03AX18 LACOSAMIDE |
| Original market date | 21-Oct-2010 |
| Current status date | 21-Oct-2010 |
| Source | Health Canada DPD |
Establishment licence of the holder
UCB Canada Inc — licence 101597, currently licensed, last inspection rating C (2024-11-12).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing LACOSAMIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02489317 | ACH-LACOSAMIDE | ACCORD HEALTHCARE INC | Tablet | LACOSAMIDE 200 MG | Marketed |
| 02489309 | ACH-LACOSAMIDE | ACCORD HEALTHCARE INC | Tablet | LACOSAMIDE 150 MG | Marketed |
| 02489295 | ACH-LACOSAMIDE | ACCORD HEALTHCARE INC | Tablet | LACOSAMIDE 100 MG | Marketed |
| 02489287 | ACH-LACOSAMIDE | ACCORD HEALTHCARE INC | Tablet | LACOSAMIDE 50 MG | Marketed |
| 02472732 | ALEMBIC-LACOSAMIDE | ALEMBIC PHARMACEUTICALS LIMITED | Tablet | LACOSAMIDE 50 MG | Approved |
| 02472740 | ALEMBIC-LACOSAMIDE | ALEMBIC PHARMACEUTICALS LIMITED | Tablet | LACOSAMIDE 100 MG | Approved |
| 02472759 | ALEMBIC-LACOSAMIDE | ALEMBIC PHARMACEUTICALS LIMITED | Tablet | LACOSAMIDE 150 MG | Approved |
| 02472767 | ALEMBIC-LACOSAMIDE | ALEMBIC PHARMACEUTICALS LIMITED | Tablet | LACOSAMIDE 200 MG | Approved |
| 02464403 | APO-LACOSAMIDE | APOTEX INC | Tablet | LACOSAMIDE 50 MG | Approved |
| 02464411 | APO-LACOSAMIDE | APOTEX INC | Tablet | LACOSAMIDE 100 MG | Approved |
| 02464438 | APO-LACOSAMIDE | APOTEX INC | Tablet | LACOSAMIDE 150 MG | Approved |
| 02464446 | APO-LACOSAMIDE | APOTEX INC | Tablet | LACOSAMIDE 200 MG | Approved |
| 02475367 | AURO-LACOSAMIDE | AURO PHARMA INC | Tablet | LACOSAMIDE 200 MG | Marketed |
| 02475359 | AURO-LACOSAMIDE | AURO PHARMA INC | Tablet | LACOSAMIDE 150 MG | Marketed |
| 02475340 | AURO-LACOSAMIDE | AURO PHARMA INC | Tablet | LACOSAMIDE 100 MG | Marketed |
| 02475332 | AURO-LACOSAMIDE | AURO PHARMA INC | Tablet | LACOSAMIDE 50 MG | Marketed |
| 02488426 | JAMP-LACOSAMIDE | JAMP PHARMA CORPORATION | Tablet | LACOSAMIDE 200 MG | Marketed |
| 02488418 | JAMP-LACOSAMIDE | JAMP PHARMA CORPORATION | Tablet | LACOSAMIDE 150 MG | Marketed |
| 02488396 | JAMP-LACOSAMIDE | JAMP PHARMA CORPORATION | Tablet | LACOSAMIDE 100 MG | Marketed |
| 02488388 | JAMP-LACOSAMIDE | JAMP PHARMA CORPORATION | Tablet | LACOSAMIDE 50 MG | Marketed |
| 02484382 | LACOSAMIDE | JUBILANT GENERICS LIMITED | Tablet | LACOSAMIDE 50 MG | Approved |
| 02484412 | LACOSAMIDE | JUBILANT GENERICS LIMITED | Tablet | LACOSAMIDE 200 MG | Approved |
| 02484404 | LACOSAMIDE | JUBILANT GENERICS LIMITED | Tablet | LACOSAMIDE 150 MG | Approved |
| 02484390 | LACOSAMIDE | JUBILANT GENERICS LIMITED | Tablet | LACOSAMIDE 100 MG | Approved |
| 02490579 | MINT-LACOSAMIDE | MINT PHARMACEUTICALS INC | Tablet | LACOSAMIDE 200 MG | Marketed |
| 02490552 | MINT-LACOSAMIDE | MINT PHARMACEUTICALS INC | Tablet | LACOSAMIDE 100 MG | Marketed |
| 02490544 | MINT-LACOSAMIDE | MINT PHARMACEUTICALS INC | Tablet | LACOSAMIDE 50 MG | Marketed |
| 02490560 | MINT-LACOSAMIDE | MINT PHARMACEUTICALS INC | Tablet | LACOSAMIDE 150 MG | Marketed |
| 02478226 | PHARMA-LACOSAMIDE | PHARMASCIENCE INC | Tablet | LACOSAMIDE 150 MG | Marketed |
| 02478234 | PHARMA-LACOSAMIDE | PHARMASCIENCE INC | Tablet | LACOSAMIDE 200 MG | Marketed |
| 02478196 | PHARMA-LACOSAMIDE | PHARMASCIENCE INC | Tablet | LACOSAMIDE 50 MG | Marketed |
| 02478218 | PHARMA-LACOSAMIDE | PHARMASCIENCE INC | Tablet | LACOSAMIDE 100 MG | Marketed |
| 02474689 | SANDOZ LACOSAMIDE | SANDOZ CANADA INCORPORATED | Tablet | LACOSAMIDE 100 MG | Marketed |
| 02474700 | SANDOZ LACOSAMIDE | SANDOZ CANADA INCORPORATED | Tablet | LACOSAMIDE 200 MG | Marketed |
| 02474697 | SANDOZ LACOSAMIDE | SANDOZ CANADA INCORPORATED | Tablet | LACOSAMIDE 150 MG | Marketed |
| 02474670 | SANDOZ LACOSAMIDE | SANDOZ CANADA INCORPORATED | Tablet | LACOSAMIDE 50 MG | Marketed |
| 02472929 | TEVA-LACOSAMIDE | TEVA CANADA LIMITED | Tablet | LACOSAMIDE 150 MG | Marketed |
| 02472902 | TEVA-LACOSAMIDE | TEVA CANADA LIMITED | Tablet | LACOSAMIDE 50 MG | Marketed |
| 02472910 | TEVA-LACOSAMIDE | TEVA CANADA LIMITED | Tablet | LACOSAMIDE 100 MG | Marketed |
| 02472937 | TEVA-LACOSAMIDE | TEVA CANADA LIMITED | Tablet | LACOSAMIDE 200 MG | Marketed |
| 02357631 | VIMPAT | UCB CANADA INC | Tablet | LACOSAMIDE 150 MG | Marketed |
| 02357658 | VIMPAT | UCB CANADA INC | Tablet | LACOSAMIDE 200 MG | Marketed |
| 02357666 | VIMPAT | UCB CANADA INC | Solution | LACOSAMIDE 10 MG | Marketed |
| 02357623 | VIMPAT | UCB CANADA INC | Tablet | LACOSAMIDE 100 MG | Marketed |
| 02487837 | ZDS-LACOSAMIDE | ZYDUS PHARMACEUTICALS (CANADA) INC | Tablet | LACOSAMIDE 200 MG | Marketed |
| 02487829 | ZDS-LACOSAMIDE | ZYDUS PHARMACEUTICALS (CANADA) INC | Tablet | LACOSAMIDE 150 MG | Marketed |
| 02487810 | ZDS-LACOSAMIDE | ZYDUS PHARMACEUTICALS (CANADA) INC | Tablet | LACOSAMIDE 100 MG | Marketed |
| 02487802 | ZDS-LACOSAMIDE | ZYDUS PHARMACEUTICALS (CANADA) INC | Tablet | LACOSAMIDE 50 MG | Marketed |
| 02501945 | AG-LACOSAMIDE | ANGITA PHARMA INC. | Tablet | LACOSAMIDE 200 MG | Dormant |
| 02501937 | AG-LACOSAMIDE | ANGITA PHARMA INC. | Tablet | LACOSAMIDE 150 MG | Dormant |
| 02501910 | AG-LACOSAMIDE | ANGITA PHARMA INC. | Tablet | LACOSAMIDE 50 MG | Dormant |
| 02501929 | AG-LACOSAMIDE | ANGITA PHARMA INC. | Tablet | LACOSAMIDE 100 MG | Dormant |
| 02499584 | NRA-LACOSAMIDE | NORA PHARMA INC | Tablet | LACOSAMIDE 150 MG | Cancelled Post Market |
| 02499568 | NRA-LACOSAMIDE | NORA PHARMA INC | Tablet | LACOSAMIDE 50 MG | Cancelled Post Market |
| 02499576 | NRA-LACOSAMIDE | NORA PHARMA INC | Tablet | LACOSAMIDE 100 MG | Cancelled Post Market |
| 02499592 | NRA-LACOSAMIDE | NORA PHARMA INC | Tablet | LACOSAMIDE 200 MG | Cancelled Post Market |
| 02474107 | PMS-LACOSAMIDE | PHARMASCIENCE INC | Tablet | LACOSAMIDE 50 MG | Cancelled Pre Market |
| 02474131 | PMS-LACOSAMIDE | PHARMASCIENCE INC | Tablet | LACOSAMIDE 200 MG | Cancelled Pre Market |
| 02474123 | PMS-LACOSAMIDE | PHARMASCIENCE INC | Tablet | LACOSAMIDE 150 MG | Cancelled Pre Market |
| 02474115 | PMS-LACOSAMIDE | PHARMASCIENCE INC | Tablet | LACOSAMIDE 100 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 11767 | 2010-09-30 | New Drug Submission (NDS) |
International API supply for LACOSAMIDE
20 valid EDQM Certificates of Suitability from 20 holders. 34 active FDA Drug Master Files.
Request a quote for VIMPAT